Investors

|

Portal
Order
Home / Research / Publications / Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

Innovation

Publications

Back

Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

– Caris Life Sciences

Poster

Conclusions

  • RCC1 expression is a negative prognostic marker in NSCLC, PC, and CRC
  • Further studies to investigate this at the molecular level may be a potential opportunity for novel targeted drug development
Download Publication

Discover
More

  • Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligence

    – Caris Life Sciences

    Manuscript

    Abstract Improved clinical outcomes are reported for patients with advanced pancreatic adenocarcinoma (PDAC) treated with first-line FOLFIRINOX/NALIRIFOX, but elderly patients with comorbidities are more often… […]

  • Adult Sarcomas with NTRK Fusions: Clinicopathologic and Genomic Heterogeneity

    – Caris Life Sciences

    Manuscript

    Simple Summary Adult sarcomas harboring NTRK fusions are rare and represent a biologically heterogeneous group with diverse morphologic, genomic, and clinical features. In this retrospective… […]
Learn More

Ready to Get Started on the Journey?